Kevin A. Link

1.3k total citations
18 papers, 650 citations indexed

About

Kevin A. Link is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Kevin A. Link has authored 18 papers receiving a total of 650 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Hematology and 3 papers in Genetics. Recurrent topics in Kevin A. Link's work include Acute Myeloid Leukemia Research (11 papers), Chromatin Remodeling and Cancer (4 papers) and Protein Degradation and Inhibitors (4 papers). Kevin A. Link is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Chromatin Remodeling and Cancer (4 papers) and Protein Degradation and Inhibitors (4 papers). Kevin A. Link collaborates with scholars based in United States, Japan and Belgium. Kevin A. Link's co-authors include James C. Mulloy, Karen E. Knudsen, Thomas W. Marshall, Fu‐Sheng Chou, Mark Wunderlich, Susumu Goyama, Benjamin Mizukawa, Erin Williams, Craig J. Burd and Erin C. Henry and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Kevin A. Link

18 papers receiving 645 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin A. Link United States 11 493 247 113 100 80 18 650
Savvas Kinalis Denmark 11 238 0.5× 155 0.6× 47 0.4× 88 0.9× 125 1.6× 16 465
Wendy A. Hudson United States 11 520 1.1× 407 1.6× 30 0.3× 44 0.4× 58 0.7× 15 720
Miriam Enos United States 5 300 0.6× 117 0.5× 52 0.5× 27 0.3× 40 0.5× 6 524
Gorica Nikoloski Netherlands 7 575 1.2× 369 1.5× 27 0.2× 52 0.5× 86 1.1× 8 717
Abhaya Paladugu United States 7 217 0.4× 116 0.5× 101 0.9× 47 0.5× 174 2.2× 9 430
Makiko Mochizuki‐Kashio Japan 15 852 1.7× 539 2.2× 48 0.4× 54 0.5× 109 1.4× 27 1.1k
Jay L. Grisolano United States 6 507 1.0× 451 1.8× 25 0.2× 90 0.9× 110 1.4× 7 678
Koorosh Korfi United Kingdom 8 228 0.5× 241 1.0× 31 0.3× 32 0.3× 81 1.0× 18 549
N Aoki Japan 10 173 0.4× 233 0.9× 34 0.3× 46 0.5× 52 0.7× 12 446
Vera Magistroni Italy 13 336 0.7× 408 1.7× 74 0.7× 29 0.3× 86 1.1× 23 783

Countries citing papers authored by Kevin A. Link

Since Specialization
Citations

This map shows the geographic impact of Kevin A. Link's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin A. Link with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin A. Link more than expected).

Fields of papers citing papers by Kevin A. Link

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin A. Link. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin A. Link. The network helps show where Kevin A. Link may publish in the future.

Co-authorship network of co-authors of Kevin A. Link

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin A. Link. A scholar is included among the top collaborators of Kevin A. Link based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin A. Link. Kevin A. Link is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Link, Kevin A., Shan Lin, Mahesh Shrestha, et al.. (2016). Supraphysiologic levels of the AML1-ETO isoform AE9a are essential for transformation. Proceedings of the National Academy of Sciences. 113(32). 9075–9080. 13 indexed citations
2.
Smith, Richard H., Archana Shrestha, Kevin A. Link, et al.. (2016). Production and purification of high-titer foamy virus vector for the treatment of leukocyte adhesion deficiency. Molecular Therapy — Methods & Clinical Development. 3. 16004–16004. 13 indexed citations
3.
Goyama, Susumu, Mahesh Shrestha, Shan Lin, et al.. (2015). UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETO. Leukemia. 30(3). 728–739. 38 indexed citations
4.
5.
Roychoudhury, Jayeeta, Jason Clark, Mark Wunderlich, et al.. (2015). MEIS1 regulates an HLF–oxidative stress axis in MLL-fusion gene leukemia. Blood. 125(16). 2544–2552. 23 indexed citations
6.
Goyama, Susumu, Lea Cunningham, Yue Zhang, et al.. (2013). Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells. Journal of Clinical Investigation. 123(9). 3876–3888. 151 indexed citations
7.
Goyama, Susumu, Lea Cunningham, Yue Zhang, et al.. (2013). Transcription factor RUNX1 promotes survival of acute myeloid leukemia cells. Journal of Clinical Investigation. 123(11). 4979–4979. 5 indexed citations
8.
Roychoudhury, Jayeeta, Jason Clark, Kevin A. Link, et al.. (2012). Genetic Models Demonstrate a Requirement of MEIS1 in Survival of MLL-AF9 Leukemia. Blood. 120(21). 120–120. 2 indexed citations
9.
Chou, Fu‐Sheng, Andrea M. Griesinger, Mark Wunderlich, et al.. (2012). The thrombopoietin/MPL/Bcl-xL pathway is essential for survival and self-renewal in human preleukemia induced by AML1-ETO. Blood. 120(4). 709–719. 40 indexed citations
10.
Ng, Kwok Peng, Quteba Ebrahem, Soledad Negrotto, et al.. (2011). p53 Independent epigenetic-differentiation treatment in xenotransplant models of acute myeloid leukemia. Leukemia. 25(11). 1739–1750. 51 indexed citations
11.
Link, Kevin A., Fu‐Sheng Chou, & James C. Mulloy. (2009). Core binding factor at the crossroads: Determining the fate of the HSC. Journal of Cellular Physiology. 222(1). 50–56. 52 indexed citations
12.
Wunderlich, Mark, Fu‐Sheng Chou, Benjamin Mizukawa, Kevin A. Link, & James C. Mulloy. (2009). A New Immunodeficient Mouse Strain, NOD/SCID IL2Rγ−/− SGM3, Promotes Enhanced Human Hematopoietic Cell Xenografts with a Robust T Cell Component.. Blood. 114(22). 3524–3524. 2 indexed citations
13.
Ng, Kwok Peng, Soledad Negrotto, Zhenbo Hu, et al.. (2009). Non-p53 Dependent, Leukemia Initiating-Cell Selective, Therapy.. Blood. 114(22). 2077–2077. 1 indexed citations
14.
Link, Kevin A., Ankur Sharma, Clay E.S. Comstock, et al.. (2008). Targeting the BAF57 SWI/SNF Subunit in Prostate Cancer: A Novel Platform to Control Androgen Receptor Activity. Cancer Research. 68(12). 4551–4558. 63 indexed citations
15.
Negrotto, Soledad, Zhenbo Hu, Kevin A. Link, et al.. (2008). Differentiation-Chronology Specific Function of DNMT1 and Selective Anti-Leukemia Stem-Cell Therapy. Blood. 112(11). 201–201. 3 indexed citations
16.
Link, Kevin A., Craig J. Burd, Erin Williams, et al.. (2005). BAF57 Governs Androgen Receptor Action and Androgen-Dependent Proliferation through SWI/SNF. Molecular and Cellular Biology. 25(6). 2200–2215. 100 indexed citations
17.
Marshall, Thomas W., et al.. (2003). Differential Requirement of SWI/SNF for Androgen Receptor Activity. Journal of Biological Chemistry. 278(33). 30605–30613. 87 indexed citations
18.
Link, Albert N. & Kevin A. Link. (2003). On the Growth of U.S. Science Parks. SSRN Electronic Journal. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Savvas Kinalis Breakdown of academic impact, for papers by Wendy A. Hudson Breakdown of academic impact, for papers by Miriam Enos Breakdown of academic impact, for papers by Gorica Nikoloski Breakdown of academic impact, for papers by Abhaya Paladugu Breakdown of academic impact, for papers by Makiko Mochizuki‐Kashio Breakdown of academic impact, for papers by Jay L. Grisolano Breakdown of academic impact, for papers by Koorosh Korfi Breakdown of academic impact, for papers by N Aoki Breakdown of academic impact, for papers by Vera Magistroni
Rankless by CCL
2026